Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Cowen sees an Attractive Long Case for Illumina (ILMN)
-
Illumina To Webcast Upcoming Investor Conference
-
Illumina (ILMN) PT Lowered to $562 at Cowen
-
Illumina (ILMN) PT Raised to $570 at Cowen
-
Illumina to Webcast Upcoming Investor Conference Presentations
-
Illumina (ILMN) PT Raised to $350 at Cowen Reporting Upside and an Encouraging Outlook
-
Illumina to Webcast Upcoming Investor Conference Presentation
-
Illumina (ILMN) to Acquire Prior Unit GRAIL for $8 Billion; Analyst Doesn't See a Clear Fit
-
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal
-
Illumina to Webcast Upcoming Investor Conference Presentations
-
Illumina (ILMN) PT Raised to $335 at Cowen
-
Illumina (ILMN) Multiple Should Improve After Biobank Program Funding - Cowen
-
Illumina (ILMN) PT Lowered to $320 at Cowen After $50M Miss
-
Illumina (ILMN) Outlook Is More Positive After A Second Look - Cowen
-
UPDATE: Illumina (ILMN) PT Raised to Street High $400 at Cowen as Momentum Building
-
Illumina (ILMN) PT Raised to $315 at Cowen
-
Illumina to Webcast Upcoming Investor Conference Presentation
-
Illumina (ILMN) PT Raised to $275 at Cowen Amid New Model
-
Illumina (ILMN): On The Path To A 50c Beat - Cowen
-
Illumina (ILMN): Solid Quarter on Strong NovaSeq Placements - Cowen
-
Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference
-
Cowen Reiterates Outperform On Illumina (ILMN), Bullish Outlook On Consensus Revisions
-
Legal Pot Business Could Get a Big Jolt on Path to $50B Industry
-
Unusual 11 Mid-Day Movers 10/11: (BSPM) (NYMX) (PSG) Higher; (RCII) (ILMN) (TPIC) Lower
-
Cowen says Thermo Fisher Scientific (TMO) buying Illumina (ILMN) is 'highly unlikely' - Bloomberg
-
Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference
-
Notable Analyst Rating Changes 10/1: (DVN) (MSFT) (JD) Upgraded; (AGCO) (ILMN) (CROX) Downgraded
-
Notable 52-Week Highs and Lows 7/1: (FIT) (ILMN) (CF) High; (BTU) (ANR) (CRK) Low
-
Illumina (ILMN) Other PTs Raised at Cowen Into Q2 Earnings Season
-
Notable Analyst Rating Changes 8/20: (ILMN) (JBLU) (DNKN) Upgraded; (SXC) (GTAT) (IDXX) Downgraded
-
Investors, Analysts Consider Roche's Bid for Illumina (ILMN) Too Low
-
Cowen Upgrades Illumina (ILMN) to Outperform
-
Notable 52-Week Highs and Lows of the Day 10/07: (CREE) (SGEN) (RAI) High; (ILMN) (RGP) (PKI) Low
-
Notable Analyst Rating Changes 10/07: (AMD) (CHK) (QTM) Upgraded; (ILMN) (HRBN) (ICE) Downgraded
-
Cowen Downgrades Illumina (ILMN) to Neutral
-
After-Hours Movers 07/26: (KEYN) (QCOR) (TPX) (ESIO) Higher; (JNPR) (CYTR) (JDAS) (ILMN) Lower